J P Chute - JoVE Visualize

Showing results (1-10 of 18) with videos related to

Pageof 2

Sort By:

Leukemia|September 3, 2011

The vascular niche: home for normal and malignant hematopoietic stem cellsP L Doan, J P Chute

Seminars in Oncology|August 1, 1997

Second lung cancers in patients successfully treated for lung cancerB E Johnson, P Cortazar, J P Chute

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 1997

Exacerbation of warfarin-induced anticoagulation by hyperthyroidismJ P Chute, C P Ryan, G Sladek, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progressJ P Chute, T Chen, E Feigal, et al.

Southern Medical Journal|June 1, 1997

Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidismK M Shakir, J P Chute, B S Aprill, et al.

Journal of the National Cancer Institute|October 6, 2000

A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancerT T Chen, J P Chute, E Feigal, et al.

Experimental Hematology|February 24, 1999

A comparative study of the cell cycle status and primitive cell adhesion molecule profile of human CD34+ cells cultured in stroma-free versus porcine microvascular endothelial cell culturesJ P Chute, A A Saini, R L Kampen, et al.

Chest|July 1, 1996

Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancerJ P Chute, M J Kelley, D Venzon, et al.

American Journal of Respiratory and Critical Care Medicine|December 31, 1997

A prospective study of patients with lung cancer and hyponatremia of malignancyB E Johnson, J P Chute, J Rushin, et al.

Mayo Clinic Proceedings|November 14, 1997

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer InstituteJ P Chute, D J Venzon, L Hankins, et al.

Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:

Pageof 2

Leukemia|September 3, 2011

The vascular niche: home for normal and malignant hematopoietic stem cellsP L Doan, J P Chute

Seminars in Oncology|August 1, 1997

Second lung cancers in patients successfully treated for lung cancerB E Johnson, P Cortazar, J P Chute

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 1997

Exacerbation of warfarin-induced anticoagulation by hyperthyroidismJ P Chute, C P Ryan, G Sladek, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999

Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progressJ P Chute, T Chen, E Feigal, et al.

Southern Medical Journal|June 1, 1997

Ferrous sulfate-induced increase in requirement for thyroxine in a patient with primary hypothyroidismK M Shakir, J P Chute, B S Aprill, et al.

Journal of the National Cancer Institute|October 6, 2000

A model to select chemotherapy regimens for phase III trials for extensive-stage small-cell lung cancerT T Chen, J P Chute, E Feigal, et al.

Experimental Hematology|February 24, 1999

Chest|July 1, 1996

Retreatment of patients surviving cancer-free 2 or more years after initial treatment of small cell lung cancerJ P Chute, M J Kelley, D Venzon, et al.

American Journal of Respiratory and Critical Care Medicine|December 31, 1997

A prospective study of patients with lung cancer and hyponatremia of malignancyB E Johnson, J P Chute, J Rushin, et al.

Mayo Clinic Proceedings|November 14, 1997

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer InstituteJ P Chute, D J Venzon, L Hankins, et al.

Pageof 2